Presentation is loading. Please wait.

Presentation is loading. Please wait.

Blood Pressure Control in Continuous Flow Left Ventricular Assist Devices: Efficacy and Impact on Adverse Events  Brent C. Lampert, DO, Chad Eckert, PhD,

Published by Modified over 6 years ago

Similar presentations

Presentation on theme: "Blood Pressure Control in Continuous Flow Left Ventricular Assist Devices: Efficacy and Impact on Adverse Events  Brent C. Lampert, DO, Chad Eckert, PhD,"— Presentation transcript:

1 Blood Pressure Control in Continuous Flow Left Ventricular Assist Devices: Efficacy and Impact on Adverse Events  Brent C. Lampert, DO, Chad Eckert, PhD, Stephanie Weaver, CRNP, Ana Scanlon, PA, Kathy Lockard, RN, Carrie Allen, RN, Nicole Kunz, RN, Christian Bermudez, MD, Jay K. Bhama, MD, Michael A. Shullo, PharmD, Robert L. Kormos, MD, Mary Amanda Dew, PhD, Jeffrey J. Teuteberg, MD  The Annals of Thoracic Surgery  Volume 97, Issue 1, Pages (January 2014) DOI: /j.athoracsur Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Blood pressure (BP) measurement algorithm. (ACE = angiotensin-converting enzyme inhibitors; ARB = angiotensin II receptor blockers; Cr = creatinine; DBP = diastolic BP; HR = heart rate; K = potassium; RV = right ventricle; SBP = systolic BP.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Mean blood pressure over time: axial versus centrifugal flow devices. (LVAD = left ventricular flow device.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Mean flow over time: axial versus centrifugal flow devices. (LVAD = left ventricular flow device.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Mean blood pressure over time: by number of blood pressure medications. (CrCl = creatinine clearance.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 5 Creatinine clearance (CrCl) over time: by number of blood pressure medications. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

7 Fig 6 Cumulative incidence of neurologic adverse events by number of antihypertensive medications. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

8 Fig 7 Degree of aortic insufficiency pre-implantation and at the end of follow-up. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

9 Fig 8 Freedom from greater than mild aortic insufficiency (AI). (BP = blood pressure; VAD = ventricular assist device.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Blood Pressure Control in Continuous Flow Left Ventricular Assist Devices: Efficacy and Impact on Adverse Events  Brent C. Lampert, DO, Chad Eckert, PhD,"

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.
Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W
Management of Anticoagulation in Patients with Mechanical Circulatory Support Using a Physician-Based Versus a Pharmacist Directed Anticoagulation Clinic-Based.

Management of Anticoagulation in Patients with Mechanical Circulatory Support Using a Physician-Based Versus a Pharmacist Directed Anticoagulation Clinic-Based.
Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes  Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,

Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes  Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,
Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 

Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 
Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant  Jaimin R. Trivedi, MD,
Michael W. A. Chu, MD, Kapil Sharma, MD, Christo I

Michael W. A. Chu, MD, Kapil Sharma, MD, Christo I
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Louis A. Brunsting, MD, Robert S. Binford, MD, Kimberly C

Louis A. Brunsting, MD, Robert S. Binford, MD, Kimberly C
Berlin Heart EXCOR Ventricular Assist Device: Multilayer Membrane Rupture in a Pediatric Patient  Arianna Di Molfetta, PhD, Sergio Filippelli, PhD, Gianfranco.

Berlin Heart EXCOR Ventricular Assist Device: Multilayer Membrane Rupture in a Pediatric Patient  Arianna Di Molfetta, PhD, Sergio Filippelli, PhD, Gianfranco.
Laura Harvey, MD, Christopher Holley, MD, Samit S

Laura Harvey, MD, Christopher Holley, MD, Samit S
Jiro Esaki, MD, PhD, Bradley G. Leshnower, MD, Jose N

Jiro Esaki, MD, PhD, Bradley G. Leshnower, MD, Jose N
Inhaled Nitric Oxide Plus Iloprost in the Setting of Post-Left Assist Device Right Heart Dysfunction  Theofani Antoniou, MD, PhD, Christos Prokakis, MD,

Inhaled Nitric Oxide Plus Iloprost in the Setting of Post-Left Assist Device Right Heart Dysfunction  Theofani Antoniou, MD, PhD, Christos Prokakis, MD,
Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation  Elizabeth A. Genovese, BS, Mary Amanda.

Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation  Elizabeth A. Genovese, BS, Mary Amanda.
Bi-Ventricular Circulatory Support With the Abiomed AB5000 System in a Patient With Idiopathic Refractory Ventricular Fibrillation  Li Zhang, MD, MS,

Bi-Ventricular Circulatory Support With the Abiomed AB5000 System in a Patient With Idiopathic Refractory Ventricular Fibrillation  Li Zhang, MD, MS,
Severity of Preoperative Aortic Regurgitation Does Not Impact Valve Durability of Aortic Valve Repair Following the David V Valve Sparing Aortic Root.

Severity of Preoperative Aortic Regurgitation Does Not Impact Valve Durability of Aortic Valve Repair Following the David V Valve Sparing Aortic Root.
Implantable Continuous-Flow Right Ventricular Assist Device: Lessons Learned in the Development of a Cleveland Clinic Device  Kiyotaka Fukamachi, MD,

Implantable Continuous-Flow Right Ventricular Assist Device: Lessons Learned in the Development of a Cleveland Clinic Device  Kiyotaka Fukamachi, MD,
Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes  Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,

Obese Patients and Mechanical Circulatory Support: Weight Loss, Adverse Events, and Outcomes  Firas Zahr, MD, Elizabeth Genovese, MS, Michael Mathier,
Impact of Preoperative Angiotensin-Converting Enzyme Inhibitor Use on Clinical Outcomes After Cardiac Surgery  Maral Ouzounian, MD, Karen J. Buth, MS,

Impact of Preoperative Angiotensin-Converting Enzyme Inhibitor Use on Clinical Outcomes After Cardiac Surgery  Maral Ouzounian, MD, Karen J. Buth, MS,
Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication?  Nishant D. Patel, BA, Jason.

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication?  Nishant D. Patel, BA, Jason.

Similar presentations

Ads by Google